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Normalization is an essential step in the analysis of high-throughput data. Multi-sample global normalization methods,
such as quantile normalization, have been successfully used to remove technical variation. However, these methods rely
on the assumption that observed global changes across samples are due to unwanted technical variability. Applying
global normalization methods has the potential to remove biologically driven variation. Currently, it is up to the subject
matter experts to determine if the stated assumptions are appropriate. Here, we propose a data-driven alternative. We
demonstrate the utility of our method (quantro) through examples and simulations. A software implementation is
available from http://www.bioconductor.org/packages/release/bioc/html/quantro.html.Background
Multi-sample normalization techniques such as quantile
normalization [1, 2] have become a standard and essen-
tial part of analysis pipelines for high-throughput data.
These techniques transform the original raw data to
remove unwanted technical variation. Technical vari-
ation can cause perceived differences between samples
processed on high-throughput technologies, irrespective
of the biological variation. These differences are typically
due to changes in experimental conditions that are hard
or impossible to control [3] and confusing them with
biological variability can lead to false discoveries [4, 5].
Some of the first attempts at normalizing microarray
data mimicked the use of so-called house-keeping
genes [6] as was done by the established gene expres-
sion measurement technology that preceded microar-
rays. This approach did not work well in practice [7, 8];
therefore, data-driven approaches were developed, such
as median correction [9, 10], variance-stabilizing trans-
formation [11], locally weighted linear regression
(loess) [12] and spline-based methods [13]. The general
idea of these approaches is to assume that observed
variability in global properties are due only to technical
reasons and are unrelated to the biology of interest [2, 14].
Here we refer to these as global adjustment methods [15].* Correspondence: rafa@jimmy.harvard.edu
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of differentially expressed genes across groups, the
median gene expression across genes and the statistical
distribution of gene expression values. These types of
assumptions are justified in many biomedical applica-
tions — for example, in gene expression studies in
which only a minority of genes (or targeted set of
genes) are expected to be differentially expressed. How-
ever, if, for example, a substantially higher percentage
of genes are expected to be expressed in only one
group of samples, it may not be appropriate to use
global adjustment methods.
Quantile normalization was originally developed for
gene expression microarrays [1, 2] but today it is applied
in a wide-range of data types, including genotyping
arrays [16, 17], RNA-Sequencing (RNA-Seq) [18–20],
DNA methylation [21], ChIP-Sequencing [22, 23] and
brain imaging [24–26]. Quantile normalization is a
global adjustment method that assumes the statistical
distribution of each sample is the same. Normalization is
achieved by forcing the observed distributions to be the
same and the average distribution, obtained by taking
the average of each quantile across samples, is used as
the reference. This method has worked very well in
practice but note that when the assumptions are not
met, global changes in distribution that may be of
biological interest will be wiped out and features that are
not different across samples can be artificially induced
[27]. A schematic of quantile normalization is provided
in Fig. 1.ess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 A schematic of quantile normalization. Quantile normalization is a non-linear transformation that replaces each feature value (row) with
the mean of the features across all the samples with the same rank or quantile. To quantile normalize a raw high-throughput data set with
multiple samples: (1) order the feature values within each sample; (2) for each feature, average across the rows; (3) substitute the raw feature
value with the average; (4) re-order the transformed values by placing in the original order
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hold have been left to the experimentalist. Graphical as-
sessments such as boxplots and density plots can be
helpful, but they do not provide a quantitative measure
of the variability. Here we propose a statistical test,
referred to as quantro, for the assumptions of global
adjustment methods, such as quantile normalization,
that tests for global differences in distributions between
groups of samples. Our test uses the raw unprocessed
high-throughput data as input to calculate a test statistic
comparing the variability of distributions within groups
relative to between groups. If the variability between
groups is sufficiently larger than the variability within
groups, then this suggests there may be global differ-
ences in distributions between groups of samples and
global adjustment methods may not be appropriate. We
demonstrate the advantages of our method by applying
it to several gene expression and DNA methylation data-
sets with targeted and global changes in distributions
(Fig. 2). We define global changes as an abundance of
differences between two or more sets of samples affect-
ing the shape or the location shift of the distributions
across groups caused by a biological or a technical source
of variation and targeted changes as differences between
sets of samples not affecting the shape or location shift of
the distributions caused by a biological or a technical
source of variation. To study the specific downstream im-
provements afforded by quantro we studied the specificity
and sensitivity of differential expression estimates with a
Monte Carlo simulation. Specifically, we studied how glo-
bal normalization methods can lead to increased bias in
downstream analyses, such as detecting differential methy-
lation, when there are global differences in the distribu-
tions and how not applying appropriate normalization
methods can lead to increased variance. We demonstrate
how by guiding the choice of a normalization technique,our method provides an overall improvement in sensitivity
and specificity.
Results
quantro: test for global differences in distributions
between groups
Consider a set of raw high-throughput data Xik represent-
ing i ∈ (1, …, nk) samples in each of the k ∈ (1, …, K)
groups (nT total samples) from a gene expression or DNA
methylation experiment. We assume Xik has some com-
mon distribution (Xik ∼ ℱk) where ℱk is the theoretical
distribution for the kth group. We define F−1ik as the
observed quantile distribution for the ith sample in the kth
group. As a first step, we use an ANOVA to test if the
average of the medians of the distributions are different
across groups and median normalize the samples accord-
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To quantify the differences between two distributions,
we use Mallow’s distance [28], which is defined as the
distance between two probability distributions over a
region (Eq. S1 in Additional file 1). We define the total
variance of the distributions as the sum of squared
differences between Fik
− 1 and F −1:: using Mallow’s distance











The total variance can be decomposed (Eqs. S2–7 in
Additional file 1) into the variance between groups
(SSbetween) and the variance within groups (SSwithin):
Fig. 2 When to use quantile normalization? Examples of gene expression data with targeted changes and global changes in distributions across
groups. a Transformed read counts from n = 65 RNA-Seq samples from the Yoruba (YRI) population and colored by genotype based on the eQTL
rs7639979: GG (blue), GA (green) and AA (red). As no global differences in distributions were detected, this suggests quantile normalization is
appropriate, but not necessary as there is a low level of variation within and between groups. b Raw perfect match (PM) values from n = 45
arrays comparing the gene expression of alveolar macrophages from nonsmokers (green), smokers (red) and patients with asthma (blue). No
global differences in distributions were detected, which indicates quantile normalization is appropriate, as it will remove any platform-based
technical variability or batch effects within groups. c Raw PM values from n = 82 arrays comparing brain and liver tissue samples. The samples
are colored by tissue (brain [red] and liver [green]), and the shades represent different Gene Expression Omnibus IDs. The global differences in
distributions detected across brain and liver tissues indicate quantile normalization is not appropriate. Global changes caused by technical
variation (e.g., batch effects across groups) will also be detected by quantro, but raw data alone cannot detect this difference





























We propose using a data-driven test statistic, referred
to as Fquantro, to test for global differences in the distri-
butions between the K groups. The null hypothesis is
that there are no global differences in the distributions
between the groups and the alternative hypothesis is that
at least one group is different from the rest.
H0 : ℱ 1 ¼ ℱ 2 ¼⋯ ¼ ℱ K
Ha : ℱ i≠ℱ j for at least one i; j
If there are no global differences in the distributions
between the groups (due to technical or biological vari-
ation), we can apply a global adjustment method, such asquantile normalization, to remove any unwanted technical
variation. If there are global differences in the distributions
between the groups, quantile normalization may not be an
appropriate normalization technique depending on the
source of variation (technical or biological variation).
The Fquantro test statistic (Eq. S8 in Additional file 1) is
a ratio of the mean squared error between groups
(MSbetween) to the mean squared error within groups
(MSwithin):
Fquantro ¼ MSbetweenMSwithin ¼
SSbetween= K−1ð Þ
SSwithin= nT−Kð Þ
We use permutation testing to assess the statistical
significance of Fquantro and reject the null hypothesis if
the p value (Eq. S9 in Additional file 1) from the permu-
tation test is less than some α significance level.
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We applied quantro to several publicly available gene
expression datasets based on both microarray and RNA-
Seq platforms (Table S1 in Additional file 1) to investi-
gate targeted and global differences in distributions
across groups. We used an α = 0.05 significance level as
the threshold to test for global changes in the distribu-
tions across groups. Examples of targeted changes in
distributions across groups are the gene expression of
samples from the Yoruba (YRI) population stratified by
genotype based on an expression quantitative trait loci
(eQTL) (p = 0.917; Fig. 2a; Figure S1 in Additional file
1), samples from two inbred mouse strains (p = 0.245;
Figure S2 in Additional file 1), samples of alveolar mac-
rophages from nonsmokers, smokers and patients with
asthma (p = 0.562; Fig. 2b; Figure S3 in Additional file
1), samples of bronchial brushings from individuals
with and without chronic obstructive pulmonary
disease (p = 0.218; Figure S4 in Additional file 1) and
samples from two regions of the brain in patients with
Parkinson’s disease (p = 0.264; Figure S5 in Additional file
1). In all of the above examples, quantile normalization is
considered appropriate because no global differences in
the distributions across groups were detected at the
α = 0.05 significance level.
When comparing the gene expression of two tissues,
we found striking global differences in the distributions
between brain and liver tissues (p = 0.004; Fig. 2c;
Figure S6 in Additional file 1). We considered multiple
studies from the Gene Expression Omnibus (GEO) to
represent each tissue to prevent batch effects [29] of
different studies from GEO being confounded with
differences in tissues. We also compared the gene expres-
sion of normal and tumor samples. We obtained multiple
studies from GEO and found global differences in the
distributions between the normal and tumor samples ofFig. 3 Biological variation in distributions of raw DNA methylation microar
from n = 46 arrays comparing adipose tissue samples from healthy men be
distributions: raw beta values from n = 35 arrays comparing six purified cel
(Bcell), CD4+ T cells (CD4T), CD56+ natural killer cells (NK), CD8+ T cells (CDlung (p < 0.001; Fig. 2d), breast (p < 0.001), prostate
(p < 0.001), thyroid (p < 0.001), stomach (p < 0.001)
and liver tissues (p = 0.044) (Figures S7–12 in Additional
file 1). We also found global changes in the distributions
of liver tissues between four groups of patients (control,
healthy obese, steatosis and nash samples) from a study
investigating the gene expression of non-alcoholic fatty
liver disease (p = 0.004; Figure S13 in Additional file 1).
Targeted and global changes in DNA methylation
In addition to gene expression, we considered three pub-
licly available DNA methylation data sets. We detected no
global differences in distributions of adipose tissues from
patients before and after six months of exercise (p = 0.132;
Fig. 3a; Figure S14 in Additional file 1) and pancreatic
tissues from non-diabetic and type 2 diabetes (p = 0.069;
Figure S15 in Additional file 1). In contrast, quantro
detected global differences in the distributions across six
purified cell types from whole blood (p < 0.001; Fig. 3b;
Figure S16 in Additional file 1), which may be relevant for
the studies estimating the cell composition of whole blood
using DNA methylation [30, 31].
quantro improves the accuracy of detecting differentially
methylated CpGs
Here we evaluate the performance of global normalization
methods in the context of targeted and global changes in
distributions with the goal of detecting differentially meth-
ylated CpGs. We performed a Monte Carlo simulation
study to illustrate how the use of global normalization
methods, such as quantile normalization, is not always
appropriate and the Fquantro test statistic can guide the
choice of normalization. For the simulation study, we
simulate DNA methylation arrays with a goal of detecting
differentially methylated CpGs, but note these results also
translate for differential gene expression. We comparerays. a Example of targeted changes in distributions: raw beta values
fore and after 6 months of exercise. b Example of global changes in
l types from whole blood: CD14+ monocytes (Mono), CD19+ B cells
8T), and granulocytes (Gran)
Hicks and Irizarry Genome Biology  (2015) 16:117 Page 5 of 8naively using quantile normalization to using quantro to
guide the decision of using either quantile normalization
or no normalization to assess the cost of using global
normalization methods in the context of distributions with
global differences.
If there is only a minority of differentially methylated
CpGs, quantile normalization reduces the bias and
mean squared error (MSE) in detecting true differences
between groups of samples because it removes un-
wanted technical variation (Figures S21 and S22 in
Additional file 1). As the number of differentially meth-
ylated CpGs increases, quantile normalization will re-
move both the unwanted technical and interesting
biological variation, resulting in higher bias and MSE
when detecting differential methylation. In contrast,
the use of quantro detects these global differences and
therefore reduces the bias and MSE compared with
using quantile normalization (Figures S21 and S22 in
Additional file 1). Similarly, the number of false discov-
eries is reduced when using quantro to guide the
normalization choice in the case when there are global
differences between groups. For example, when consid-
ering a 450K DNA methylation array if there are only a
small number of differentially methylated CpGs (1 % of
CpGs or 4500 CpGs), quantro and quantile normalization
are comparable in the number of false discoveries (873
and 873, respectively), but if there are global differences
in the distributions between groups (10 % of CpGs or
45,000 CpGs), quantro is able to detect those global
differences and reduce the number of false discoveries
compared with quantile normalization (4887 and 6583,
respectively) (Figure S23 in Additional file 1). Using
quantro gives researchers a data-driven tool to test if
global normalization methods are appropriate, such as
quantile normalization, which can result in larger bias,
MSE and more false discoveries when detecting differ-
entially methylated CpGs in the context of global
differences in distributions.
In addition, we considered the true positive rate and
false positive rate of using quantile normalization and
using quantro to guide the choice of normalization
while varying the threshold of the number of top differ-
entially methylated CpGs selected. If there are only a
small number of differentially methylated CpGs, quan-
tile normalization and quantro are comparable in per-
formance, but when the proportion of differentially
methylated CpGs increases, quantile normalization fails
to detect global differences between the groups, result-
ing in lower sensitivity and specificity (Figure S24 in
Additional file 1). Using quantro as a tool to determine
which type of normalization approach to employ results
in higher sensitivity and specificity when detecting true
differentially methylated CpGs compared with naively
using quantile normalization.Discussion
The advent of high-throughput technologies brought the
opportunity for researchers to investigate and assess
biological variability at the genomic level, but it also
introduced unwanted technical variability that can cause
perceived differences between samples processed on
high-throughput technologies, irrespective of the bio-
logical variation. These differences may be due to dif-
ferences in the way the samples were processed (such
as batch effects) or to platform-dependent technical
variation. Because global changes in distributions be-
tween groups can be caused by both technical variation
and biological variation, it is important to note that our
test statistic Fquantro will detect global differences
caused by both technical variation (e.g., batch effects)
and biological variation. Data alone cannot determine if
global changes are caused by technical variation or bio-
logical variation (Fig. 2), but quantro offers researchers
a new tool to detect when there are global changes in
distributions across groups.
As quantro assess the assumptions of global normalization
methods, it is important to note other global normalization
methods such as VSN [11], Loess [12] and the trimmed
mean method [32] make different assumptions about the
true biological variability [33]. For example, the trimmed
mean method assumes most genes are not differentially
expressed and uses a global linear scaling factor for
normalization. Similarly, Loess uses local scaling factors in
a moving window. In contrast to scaling factors, VSN is
based on a slightly different assumption that the variance
is constant and transforms the raw data such that the vari-
ance is constant across expression levels, reducing the
variability observed in regions with low expression. The
method introduced here, quantro, is not a normalization
method, but rather it tests the assumptions of global
normalization methods that assume there are no global dif-
ferences in the distributions to guide the choice or whether
or not global normalization methods are appropriate.
Here, we have shown if there are global changes in the
distributions across a set of groups, normalization
methods with global adjustments may not be appropri-
ate depending on the type and source of variation. If
global adjustment methods are not appropriate, other
methods, such as application-specific methods [15], can
be used. These are normalization methods where the
adjustments are directly incorporated into the experi-
ment or main analysis. Examples of these methods
include the use of positive and negative control genes,
the use of spike-in controls and explicitly modeling
known or unknown effects of unwanted variation in a
linear model (see Section 5 in Additional file 1 for more a
more detailed discussion on application-specific methods).
It is important to note that some of the application-
specific methods, such as SVA [34] and PEER [35], are
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differences as these are often captured by the first princi-
pal components. In addition, methods that rely on control
genes, such as RUV [15], are similar to other forms of
global normalization methods such as subset quantile
normalization.
Previous studies have evaluated and discussed
normalization methods with and without global adjust-
ments [2, 15, 32, 36], but the decision of which type of
normalization method to use depends on the outcome
of interest. For example, a recent study [27] discussed
the use of normalization procedures in global gene
expression analysis comparing two schematics: targeted
changes in gene expression and global changes in gene
expression such as transcriptional amplification [37] or
transcriptional shutdown [38]. Not surprisingly, the au-
thors show normalization methods with global adjust-
ments are not appropriate if the total RNA is not the
same across the samples. In this case, if normalization
is performed at the experimental level (introducing
similar amounts of RNA into the assay from the two
groups with global changes), then we suggest using
control genes or spike-in controls as no differences
between the distributions will be detected (Figure S25
in Additional file 1). However, for the great majority of
studies such strategies are not available. Furthermore, if
one knows a priori that most genes are differentially
expressed, then high-throughput technologies may not be
the optimal tool as these technologies are mainly used and
have been optimized for finding specific genes that are dif-
ferentially expressed between groups of samples.
Conclusions
Normalization methods with global adjustments are
widely used for data analysis in genomics, but rely on
assumptions about the data generation process that are
not appropriate in certain contexts. To the best of our
knowledge, there is no quantitative method available to
assess if the stated assumptions are appropriate or not,
leaving the decision up to subject matter experts. Our
method is the first to provide a data-driven solution to
test the assumptions of global normalization methods.
We have demonstrated the utility of our method by
applying it to several gene expression and DNA methy-
lation datasets, revealing examples of both targeted and
global changes in distributions across groups, such as the
global changes in distributions detected between the gene
expression of brain and liver tissues. We demonstrated
that global normalization methods can lead to increased
bias and MSE in downstream analyses when there are
global differences in distributions and quantro can
detect when global normalization methods are not
appropriate, which can prevent removing potentially in-
teresting biological variation. We have implementedour method into the quantro R-package providing re-
searchers a tool to test the assumptions of global
normalization methods in the analysis of their own data.
Materials and methods
Data analysis
The method introduced here has been implemented
into the quantro R-package available on Bioconductor.
We used permutation testing to assess the statistical
significance of the test statistic and distributed the
computations across multiple cores to increase the
speed. To test for global differences in distributions
between groups of samples from high-throughput data
sets, we applied quantro to several publicly available
gene expression and DNA methylation data sets. Table
S1 in Additional file 1 contains a list of all the data sets.
For this analyses, we use the α = 0.05 significance level
as the threshold to detect global changes in the distri-
butions across groups.
To compare the gene expression on microarrays of
cancer samples and brain and liver tissues, we consid-
ered multiple studies from GEO [39] to represent each
tissue to prevent batch effects of different studies from
GEO being confounded with differences between can-
cer samples or between tissues. For the gene expression
samples using microarrays, we extracted the raw per-
fect match (PM) values from the CEL files using the
affy R/Bioconductor package [40]. To visualize the true
biological variation in the experimentally normalized
samples from Lovén et al. [27], we divided the raw PM
values by the sample mean of the PM values across the
spike-ins on the log2 scale. For the gene expression
samples using RNA-Seq, we used the rlogTransforma-
tion provided in the DESeq2 R/Bioconductor package
[41] to transform the raw counts to the log2 scale,
which reduces the variability in the low counts, but
other transformations can be used such as the Variance
Stabilizing Transformation (VST) in the DESeq2 pack-
age. The RNA-Seq data were obtained from ReCount
[42], which pre-processes the raw sequencing data and
provides a table of raw counts for each gene. We removed
all the rows with zero counts across all the samples. For
the DNA methylation samples using microarrays, we used
the minfi R/Bioconductor package [43]. We extracted the
raw methylated and unmethylated signal using and com-
puted the ‘beta’-values using Illumina’s default setting of
the offset parameter equal to 100.
Details for simulation studies
We developed an R package, referred to as quantroSim
(Section 3 in Additional file 1), which is available on
GitHub, to simulate gene expression and DNA methy-
lation data, but here we just focus on DNA methyla-
tion. To simulate samples on a microarray platform
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to model the chemical saturation in the hybridization of
the probes. Each of the simulation studies considered two
groups with five samples each (total of ten samples).
With the goal of detecting differentially methylated
CpGs, we compared the performance of quantro to the
naïve approach of always using quantile normalization
where quantro uses the Fquantro test statistic to decide if
quantile normalization is appropriate (no normalization
otherwise; Section 4 in Additional file 1). For the permu-
tation testing in quantro, we used 100 permutations and
a cutoff threshold of α = 0.05, unless specified otherwise.
After normalization, the difference between the group
means were estimated and the top differentially methyl-
ated probes were found using a t-test.
We assessed the relative bias (bias from quantro to the
bias from quantile normalization) and relative MSE
while varying the cutoff threshold from quantro and for
a fixed threshold at α = 0.05. We simulated DNA methy-
lation samples with a varying proportion of differentially
methylated CpGs between the two groups and a varying
level of technical variation (see Sections 3 and 4 in
Additional file 1 for more details).
To select a list of top differentially methylated probes,
we adjusted the p values from a t-test using the Benjamini
and Hochberg adjustment to correct for multiple testing.
The number of false discoveries was calculated using as
the number of incorrectly selected probes from a given set
of top differentially methylated probes. The true positive
rate was calculated as the number of correctly selected
probes from the set of true differentially methylated
probes. In contrast, the false positive rate was calculated
as the number of incorrectly selected probes from the set
of probes that are not differentially expressed.Software
The R-package quantro implementing our method is avail-
able in Bioconductor 3.1 [45]) (software license GNU GPL
3.0) and the quantroSim R-package to simulate gene
expression and DNA methylation data is available on
GitHub [46].Additional file
Additional file 1: Supplementary materials are available in a single
pdf. All scripts containing the code for these analyses are available on
GitHub [47].Abbreviations
GEO: Gene Expression Omnibus; MSE: mean squared error; PM: perfect
match.
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